By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Kowa Pharmaceuticals America 

5331 Perimeter Parkway Court

Montgomery  Alabama  36116  U.S.A.
Phone: 334-288-1288 Fax: 334-288-2788


SEARCH JOBS


Industry
Pharmaceutical






Company News
Kowa Pharmaceuticals America Release: Data Showed After 52 Weeks, LIVALO® (Pitavastatin) 4 Mg Maintained Similar Safety And Significantly Greater LDL-C Reduction Compared With Pravastatin 40 Mg In HIV-Infected Adults With Dyslipidemia 5/1/2014 8:57:52 AM
Amarin Corporation PLC (AMRN) And Kowa Pharmaceuticals America Announce U.S. Co-Promotion Agreement For Vascepa® (Icosapent Ethyl) Capsules 4/1/2014 11:05:15 AM
Kowa Pharmaceuticals America Release: New Data Showed LIVALO® (pitavastatin) 4 mg had Neutral Effects on Fasting Serum Glucose and HbA1c Levels in HIV-infected Adults with Dyslipidemia 6/17/2013 11:46:12 AM
Kowa Pharmaceuticals America Release: New Superiority Trial Showed LIVALO® (Pitavastatin) 4 mg Provided Significantly Greater LDL-C Reduction in HIV-Infected Adults With Dyslipidemia Versus Pravastatin 40 mg 3/7/2013 10:21:35 AM
Kowa Pharmaceuticals America, Eli Lilly and Company (LLY) Release Results From a Pharmacokinetic Study 7/23/2012 7:54:22 AM
John O'Hurley Teams Up With the National Lipid Association, Kowa Pharmaceuticals America and Eli Lilly and Company (LLY) to Announce Results of Landmark Statin USAGE Survey, Largest Known Survey of Cholesterol Patients 6/19/2012 9:06:23 AM
Eli Lilly and Company (LLY) and Kowa Pharmaceuticals America Reveal Positive Results of PREVAIL US Study 5/31/2012 7:33:36 AM
Kowa Pharmaceuticals America Release: New Study Data Published Assessing the Effect of LIVALO(R) vs. Crestor(R) on International Normalized Ratio on Steady-State Warfarin 2/13/2012 9:53:49 AM
Kowa Pharmaceuticals America Release: New Data Showed Minimal Potential for Drug Interaction Between Cholesterol Drug LIVALO® and a Common Antiretroviral Therapy 7/18/2011 5:59:10 AM
Cipher Pharmaceuticals (DND.TO) Achieves Sales Milestone For Lipofen(R); Triggering $1 Million From Kowa Pharmaceuticals America 7/7/2010 7:13:26 AM
12
//-->